{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T10:27:30Z","timestamp":1776853650868,"version":"3.51.2"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2012,12,19]],"date-time":"2012-12-19T00:00:00Z","timestamp":1355875200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Neurol Belg"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1007\/s13760-012-0166-2","type":"journal-article","created":{"date-parts":[[2012,12,18]],"date-time":"2012-12-18T01:44:53Z","timestamp":1355795093000},"page":"257-263","source":"Crossref","is-referenced-by-count":56,"title":["Preventive effect of vitamin D3 supplementation on conversion of optic neuritis to clinically definite multiple sclerosis: a double blind, randomized, placebo-controlled pilot clinical trial"],"prefix":"10.1007","volume":"113","author":[{"given":"Hajar","family":"Derakhshandi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masoud","family":"Etemadifar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Awat","family":"Feizi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyed-Hossein","family":"Abtahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alireza","family":"Minagar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad-Ali","family":"Abtahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra-Alsadat","family":"Abtahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alireza","family":"Dehghani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sepideh","family":"Sajjadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nasim","family":"Tabrizi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,12,19]]},"reference":[{"issue":"1","key":"166_CR1","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/ana.10240","volume":"52","author":"CM Dalton","year":"2002","unstructured":"Dalton CM, Brex PA, Miszkiel KA, Hickman SJ, MacManus DG, Plant GT, Thompson AJ, Miller DH (2002) Application of the new McDonald criteria to patients with clinically isolated syndromes suggestive of multiple sclerosis. Ann Neurol 52(1):47\u201353","journal-title":"Ann Neurol"},{"issue":"2","key":"166_CR2","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1177\/1756285611398702","volume":"4","author":"E Voss","year":"2011","unstructured":"Voss E, Raab P, Trebst C, Stangel M (2011) Clinical approach to optic neuritis: pitfalls, red flags and differential diagnosis. Ther Adv Neurol Disord 4(2):123\u2013134","journal-title":"Ther Adv Neurol Disord"},{"issue":"9349","key":"166_CR3","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1016\/S0140-6736(02)11919-2","volume":"360","author":"SJ Hickman","year":"2002","unstructured":"Hickman SJ, Dalton CM, Miller DH, Plant GT (2002) Management of acute optic neuritis. Lancet 360(9349):1953\u20131962","journal-title":"Lancet"},{"issue":"4","key":"166_CR4","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1007\/s00415-005-0655-9","volume":"252","author":"P Nilsson","year":"2005","unstructured":"Nilsson P, Larsson EM, Maly-Sundgren P, Perfekt R, Sandberg-Wollheim M (2005) Predicting the outcome of optic neuritis: evaluation of risk factors after 30\u00a0years of follow-up. J Neurol 252(4):396\u2013402","journal-title":"J Neurol"},{"key":"166_CR5","unstructured":"No authors listed (1977) The 5\u00a0year risk of MS after optic neuritis. Experience of the optic neuritis treatment trial. Optic Neuritis Study Group. Neurology 49(5): 1404\u20131413"},{"issue":"2","key":"166_CR6","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.bbadis.2010.07.017","volume":"1812","author":"HEC Hanwell","year":"2011","unstructured":"Hanwell HEC, Banwell B (2011) Assessment of evidence for a protective role of vitamin D in multiple sclerosis. Biochim et Biophys Acta (BBA)-Mol Basis Dis 1812(2):202\u2013212","journal-title":"Biochim et Biophys Acta (BBA)-Mol Basis Dis"},{"issue":"3","key":"166_CR7","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1093\/ajcn\/86.3.645","volume":"86","author":"S Kimball","year":"2007","unstructured":"Kimball S, Ursell M, O\u2019Connor P, Vieth R (2007) Safety of vitamin D3 in adults with multiple sclerosis. Am J Clin Nutr 86(3):645","journal-title":"Am J Clin Nutr"},{"issue":"23","key":"166_CR8","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1212\/WNL.0b013e3181e1cec2","volume":"74","author":"J Burton","year":"2010","unstructured":"Burton J, Kimball S, Vieth R, Bar-Or A, Dosch H, Cheung R et al (2010) A phase I\/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis. Neurology 74(23):1852","journal-title":"Neurology"},{"issue":"5","key":"166_CR9","first-page":"313","volume":"3","author":"M Etemadifar","year":"2012","unstructured":"Etemadifar M, Abtahi SH, Razmjoo H, Abtahi MA, Dehghani A, Salari M, Maghzi AH, Akbari M (2012) 25-Hydroxyvitamin D concentrations in patients with optic neuritis as a clinically isolated syndrome and healthy controls. Int J Prev Med 3(5):313\u2013317","journal-title":"Int J Prev Med"},{"issue":"9","key":"166_CR10","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1136\/jnnp.2004.056499","volume":"76","author":"DM Wingerchuk","year":"2005","unstructured":"Wingerchuk DM, Lesaux J, Rice GP, Kremenchutzky M, Ebers GC (2005) A pilot study of oral calcitriol (1,25-dihydroxyvitamin D3) for relapsing-remitting multiple sclerosis. J Neurol Neurosurg Psychiatry 76(9):1294\u20131296","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"166_CR11","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/ana.20703","volume":"58","author":"CH Polman","year":"2005","unstructured":"Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L, Lublin FD, Metz LM, McFarland HF, O\u2019Connor PW, Sandberg-Wollheim M, Thompson AJ, Weinshenker BG, Wolinsky JS (2005) Diagnostic criteria for multiple sclerosis: 2005 revisions to the \u2018\u2018McDonald Criteria\u2019\u2019. Ann Neurol 58(6):840\u2013846","journal-title":"Ann Neurol"},{"issue":"1\u20132","key":"166_CR12","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jneuroim.2007.11.014","volume":"194","author":"J Smolders","year":"2008","unstructured":"Smolders J, Damoiseaux J, Menheere P, Hupperts R (2008) Vitamin D as an immune modulator in multiple sclerosis, a review. J Neuroimmunol 194(1\u20132):7\u201317","journal-title":"J Neuroimmunol"},{"issue":"1\u20132","key":"166_CR13","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S0165-5728(02)00396-X","volume":"134","author":"B Mahon","year":"2003","unstructured":"Mahon B, Gordon S, Cruz J, Cosman F, Cantorna M (2003) Cytokine profile in patients with multiple sclerosis following vitamin D supplementation. J Neuroimmunol 134(1\u20132):128\u2013132","journal-title":"J Neuroimmunol"},{"issue":"1","key":"166_CR14","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.optm.2011.10.010","volume":"83","author":"NR Holdeman","year":"2012","unstructured":"Holdeman NR, Nguyen T, Tang RA (2012) Demyelinating optic neuritis presenting as a clinically isolated syndrome. Optometry 83(1):9\u201318","journal-title":"Optometry"},{"key":"166_CR15","doi-asserted-by":"crossref","unstructured":"Faridar A, Eskandari G, Sahraian MA, Minagar A, Azimi A (2012) Vitamin D and multiple sclerosis: a critical review and recommendations on treatment. Acta Neurol Belg (Epub ahead of print)","DOI":"10.1007\/s13760-012-0108-z"},{"key":"166_CR16","doi-asserted-by":"crossref","unstructured":"Kirbas A, Kirbas S, Anlar O, Turkyilmaz AK, Cure MC, Efe H (2012) Investigation of the relationship between vitamin D and bone mineral density in newly diagnosed multiple sclerosis. Acta Neurol Belg (Epub ahead of print)","DOI":"10.1007\/s13760-012-0123-0"},{"issue":"1","key":"166_CR17","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1212\/01.WNL.0000101723.79681.38","volume":"62","author":"K Munger","year":"2004","unstructured":"Munger K, Zhang S, O\u2019Reilly E, Hernan M, Olek M, Willett W et al (2004) Vitamin D intake and incidence of multiple sclerosis. Neurology 62(1):60","journal-title":"Neurology"},{"issue":"23","key":"166_CR18","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1001\/jama.296.23.2832","volume":"296","author":"K Munger","year":"2006","unstructured":"Munger K, Levin L, Hollis B, Howard N, Ascherio A (2006) Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 296(23):2832","journal-title":"JAMA"},{"issue":"3","key":"166_CR19","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1191\/1352458505ms1157oa","volume":"11","author":"M Soilu-Hanninen","year":"2005","unstructured":"Soilu-Hanninen M, Airas L, Mononen I, Heikkila A, Viljanen M, Hanninen A (2005) 25-Hydroxyvitamin D levels in serum at the onset of multiple sclerosis. Mult Scler 11(3):266","journal-title":"Mult Scler"},{"issue":"5","key":"166_CR20","first-page":"301","volume":"3","author":"M Etemadifar","year":"2012","unstructured":"Etemadifar M, Abtahi SH (2012) Multiple sclerosis in Isfahan, Iran: past, present and future. Int J Prev Med 3(5):301\u2013302","journal-title":"Int J Prev Med"}],"container-title":["Acta Neurologica Belgica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-012-0166-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13760-012-0166-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-012-0166-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,7]],"date-time":"2019-07-07T00:40:46Z","timestamp":1562460046000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13760-012-0166-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12,19]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["166"],"URL":"https:\/\/doi.org\/10.1007\/s13760-012-0166-2","relation":{},"ISSN":["0300-9009","2240-2993"],"issn-type":[{"value":"0300-9009","type":"print"},{"value":"2240-2993","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,19]]}}}